Antho 50 (bilberry extract enriched with anthocyanins) treatment induces the down-regulation of the UHRF1 protein in B cell chronic lymphocytic leukemic cells and promotes apoptosis through the activation of caspase-3, inhibition of Bcl-2 (B-cell lymphoma), and dephosphorylation of Akt and Bad (BCL2-associated agonist of cell death) [134,135]. Here, BCL2 is linked to B-cell non-Hodgkin lymphoma.